Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 399.93%5.29B | 468.73%3.59B | 548.78%1.65B | 134.78%3.7B | 11.06%1.06B | 9.74%631.1M | 10.55%254.47M | 2.42%1.57B | -1.63%952.31M | 1.08%575.11M |
| Refunds of taxes and levies | 76.30%34.51M | 86.96%20.14M | 160.80%11.36M | -24.99%42.91M | -50.26%19.58M | -46.52%10.77M | -69.68%4.36M | -10.98%57.21M | 20.89%39.36M | 220.91%20.15M |
| Cash received relating to other operating activities | 402.74%126.49M | 399.90%100.68M | 1,625.64%99.36M | 113.83%112.42M | -30.75%25.16M | -47.40%20.14M | -38.53%5.76M | -0.11%52.57M | 27.49%36.33M | -24.63%38.29M |
| Adjustment items of operating cash inflws | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from operating activities | 394.24%5.45B | 460.42%3.71B | 565.83%1.76B | 128.70%3.85B | 7.23%1.1B | 4.49%662.01M | 4.20%264.58M | 1.82%1.68B | -0.11%1.03B | 1.20%633.55M |
| Goods services cash paid | 577.41%2.25B | 707.97%1.5B | 726.03%822.34M | 23.12%680.47M | -18.62%331.94M | -17.35%186.16M | -21.75%99.55M | 22.73%552.71M | 63.19%407.91M | 11.10%225.23M |
| Staff behalf paid | 309.74%3.75B | 329.48%2.68B | 337.40%1.3B | 32.03%1.53B | -2.56%915.4M | -1.87%624.46M | -15.76%298.32M | 5.13%1.16B | 6.01%939.44M | 10.24%636.35M |
| All taxes paid | 561.77%337.4M | 601.20%250.41M | 879.40%172M | 52.30%183.08M | -37.67%50.98M | -25.02%35.71M | -35.10%17.56M | -4.14%120.21M | -11.02%81.79M | -30.51%47.63M |
| Cash paid relating to other operating activities | 50.25%288.89M | 71.07%198.25M | 176.45%148.08M | 35.05%312.92M | -7.58%192.27M | -4.02%115.89M | 6.41%53.57M | -2.13%231.71M | 1.78%208.04M | -11.52%120.75M |
| Cash outflows from operating activities | 344.50%6.63B | 381.66%4.63B | 421.80%2.45B | 31.16%2.71B | -8.95%1.49B | -6.58%962.23M | -16.06%469M | 7.77%2.06B | 14.29%1.64B | 4.57%1.03B |
| Adjustment items of net operating cash flow | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash flows from operating activities | -203.25%-1.18B | -207.99%-924.65M | -235.38%-685.57M | 401.95%1.15B | 36.27%-388.26M | 24.27%-300.22M | 32.94%-204.41M | -45.50%-379.34M | -51.04%-609.18M | -10.44%-396.42M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 233.43%1.97B | 382.10%1.92B | 3,182.07%1.18B | -80.70%722.05M | -79.57%592M | -77.09%399M | -92.00%36M | -38.71%3.74B | -24.48%2.9B | -26.23%1.74B |
| Cash received from returns on investments | 344.40%13.01M | 423.63%12.64M | 3,014.23%4.25M | -76.91%7.74M | -88.32%2.93M | -85.76%2.41M | -98.46%136.47K | -10.36%33.52M | 13.90%25.06M | 15.02%16.94M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 415.50%252.04K | 79.58%84.57K | 775.51%39.89K | 56.26%86.93K | 220.75%48.89K | 298.26%47.1K | -40.85%4.56K | 232.45%55.63K | 26.79%15.24K | 29.16%11.83K |
| Net cash received from disposal of subsidiaries and other business units | --89.63K | --89.63K | --89.63K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Adjustment iems of investing cash inflows | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- |
| Cash inflows from investing activities | 234.01%1.99B | 382.34%1.94B | 3,181.38%1.19B | -80.67%729.87M | -79.64%594.98M | -77.17%401.46M | -92.12%36.14M | -38.53%3.78B | -24.26%2.92B | -25.98%1.76B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 250.95%53.77M | 239.06%44.68M | 842.81%24.4M | -15.21%37.34M | -61.61%15.32M | -31.38%13.18M | -53.42%2.59M | -8.18%44.04M | 1.78%39.91M | -18.52%19.2M |
| Cash paid to acquire investments | 176.80%1.82B | 246.38%1.63B | 231.69%1.07B | -76.10%924.25M | -80.99%659M | -82.62%471M | -80.00%323M | -36.87%3.87B | -32.79%3.47B | -21.20%2.71B |
| Net cash paid to acquire subsidiaries and other business units | --6.87M | ---- | --2M | 146.23%728.45M | ---- | ---- | ---- | --295.84M | ---- | ---- |
| Cash outflows from investing activities | 179.51%1.88B | 246.18%1.68B | 237.16%1.1B | -59.83%1.69B | -80.77%674.32M | -82.26%484.18M | -79.91%325.59M | -31.85%4.21B | -32.53%3.51B | -21.18%2.73B |
| Net cash flows from investing activities | 229.20%102.51M | 414.64%260.26M | 130.46%88.17M | -122.62%-960.17M | 86.39%-79.35M | 91.48%-82.72M | 75.08%-289.45M | -1,311.84%-431.3M | 56.39%-583.17M | 10.70%-970.59M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | --660K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --660K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 122.79%692.2M | -81.20%37.52M | ---- | 413.18%1.08B | --310.69M | --199.64M | --54.01M | --210.15M | ---- | ---- |
| Cash received relating to other financing activities | -95.19%28.98M | -94.70%31.88M | ---- | --601.87M | 2,049.55%601.87M | --601.87M | --1.87M | ---- | --28M | ---- |
| Cash inflows from financing activities | -20.97%721.17M | -91.34%69.4M | ---- | 699.90%1.68B | 3,159.15%912.56M | --801.51M | --55.88M | -81.73%210.15M | -97.56%28M | ---- |
| Borrowing repayment | 541.49%894.89M | 185.05%81.79M | 98.09%56.74M | 784,954.75%392.53M | --139.5M | --28.69M | --28.64M | --50K | ---- | ---- |
| Dividend interest payment | 5,710.58%368.44M | 8,548.73%351.28M | 376.61%7.99M | 20.22%11.87M | -35.17%6.34M | --4.06M | --1.68M | -82.37%9.87M | -82.54%9.78M | ---- |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | --276.62M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | 655.04%171.97M | 224.62%62.26M | 527.12%42.97M | -63.65%119.09M | -93.50%22.78M | -89.91%19.18M | -78.83%6.85M | 372.64%327.61M | 594.45%350.42M | 355.10%190.15M |
| Cash outflows from financing activities | 751.21%1.44B | 853.74%495.33M | 189.73%107.7M | 55.09%523.48M | -53.19%168.62M | -72.69%51.94M | 14.83%37.17M | 169.34%337.53M | 238.25%360.2M | 355.10%190.15M |
| Net cash flows from financing activities | -195.99%-714.13M | -156.82%-425.93M | -675.74%-107.7M | 1,008.66%1.16B | 323.94%743.94M | 494.20%749.57M | 157.79%18.71M | -112.43%-127.39M | -131.91%-332.2M | -117.20%-190.15M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -68.60%-1.77M | -931.51%-1.6M | -4,816.94%-419.41K | 1,159.99%1.5M | -313.42%-1.05M | -448.12%-155K | 111.49%8.89K | -127.89%-141.85K | -43.45%491.05K | -88.09%44.52K |
| Net increase in cash and cash equivalents | -750.50%-1.79B | -397.94%-1.09B | -48.48%-705.51M | 243.29%1.34B | 118.06%275.29M | 123.54%366.48M | 68.30%-475.15M | -227.75%-938.16M | -118.14%-1.52B | -358.34%-1.56B |
| Add:Begin period cash and cash equivalents | 127.57%2.4B | 127.57%2.4B | 127.57%2.4B | -47.10%1.05B | -47.10%1.05B | -47.10%1.05B | -47.10%1.05B | 58.40%1.99B | 58.40%1.99B | 58.40%1.99B |
| End period cash equivalent | -54.31%607.21M | -8.04%1.31B | 192.51%1.69B | 127.57%2.4B | 184.08%1.33B | 226.64%1.42B | 17.37%578.6M | -47.10%1.05B | -16.28%467.84M | -52.63%434.8M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.